Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [12335]

Enzalutamide shows efficacy in preventing aggressive prostate cancer becoming metastatic, deadly

Enzalutamide shows efficacy in preventing aggressive prostate cancer becoming metastatic, deadly

Fluciclovine PET/CT locates recurrent prostate cancer and advises management

Fluciclovine PET/CT locates recurrent prostate cancer and advises management

Poliovirus therapy for recurrent glioblastoma has three year survival rate of 21 percent

Poliovirus therapy for recurrent glioblastoma has three year survival rate of 21 percent

New regulatory axis revealed for the cancer relevant matrix metalloprotease MMP14

New regulatory axis revealed for the cancer relevant matrix metalloprotease MMP14

Research on cancer-frying nanoparticles heats up

Research on cancer-frying nanoparticles heats up

Clinical care for transgender cancer patients starts with caring about transgender cancer patients

Clinical care for transgender cancer patients starts with caring about transgender cancer patients

Researchers discover a new type of lung cancer

Researchers discover a new type of lung cancer

Immune profile for successful cancer immunotherapy discovered

Transport of lipid-conjugated floxuridine by natural serum albumin for delivery to cancer cells

Transport of lipid-conjugated floxuridine by natural serum albumin for delivery to cancer cells

First major study comparing robotic to open surgery published

First major study comparing robotic to open surgery published

More from ecancer